VDFA
BIIB icon

Vickerman & Driscoll Financial Advisors’s Biogen BIIB Stock Holding History

Vickerman & Driscoll Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-42
Closed -$15K – 71
2018
Q3 		$15K Hold
42
– – 0.01% 98
2018
Q2 		$12K Hold
42
– – 0.01% 99
2018
Q1 		$12K Sell
42
-18
-30% -$5.59K 0.01% 98
2017
Q4 		$19K Buy
+60
New +$19.2K 0.01% 92

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vickerman & Driscoll Financial Advisors's BIIB Position: Q4 2018 in Review

Vickerman & Driscoll Financial Advisors sold out of Biogen (BIIB) in Q4 2018, closing a stake of 42 shares — an estimated $15K sold.

Vickerman & Driscoll Financial Advisors first reported a position in BIIB in Q4 2017 and held it in 4 quarters. The position peaked at $19K in Q4 2017. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Vickerman & Driscoll Financial Advisors reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Vickerman & Driscoll Financial Advisors sold 42 Biogen shares in Q4 2018, an estimated $15K.
  • Vickerman & Driscoll Financial Advisors first reported a position in Biogen in Q4 2017 and held it in 4 quarters.
  • Vickerman & Driscoll Financial Advisors's Biogen position peaked at $19K in Q4 2017.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Vickerman & Driscoll Financial Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.